Is Vaping Marijuana Safer than Smoking it?

Aug.03.2022
Is Vaping Marijuana Safer than Smoking it?
Electronic cannabis vaporizers offer a safer alternative to smoking, but concerns remain about unregulated products and potential health risks.

Marijuana e-cigarettes are believed to be a safer alternative to smoking. Users can still benefit from all the advantages of cannabinoids and terpenes without inhaling carbon monoxide, particulate matter from plants, or over 100 toxins released during combustion.


However, a few years ago, the outbreak of lung disease (mostly related to the use of illegal THC oil) challenged this sense of safety. Acetate vitamin E, a cheap thickening agent used for diluting oil, was identified as the culprit and quickly removed from products. However, it may still persist in illegal oils and e-cigarettes.


Despite a sharp decline in the incidence of lung disease related to electronic vapor products, or EVALI, since reaching its peak in September 2019, concerns about the safety of marijuana vaporization persist in peer-reviewed scientific reports and mainstream media sources. While numerous articles have been written comparing the pros and cons of vaping electronic cigarettes versus consuming marijuana, it is important to revisit this issue in the post-vitamin E acetate era for comparison.


Why cannabis?


According to reports, the popularity of vaping cannabis is increasing along with the legal availability. However, vaping is rarely the sole method of consuming cannabis, as only 13% exclusively vape it. People often opt to vape cannabis instead of smoking it because it is more convenient, discreet, and efficient. Sometimes, people simply do not want their space to smell like weed.


E-cigarettes are also considered a safer choice because heating the liquid rarely exceeds 400°F, whereas burning flowers can reach close to 500°F, thus reducing the amount of harmful gases and toxins inhaled.


In addition, for those seeking specific and replicable effects, cannabinoids such as tetrahydrocannabinol (THC) or cannabidiol (CBD) and terpenes found in vaping cartridges can provide consistent results.


Furthermore, by adding cannabinoids and terpenes to traditional cultivation methods and strain genetics, optimization can be tailored to specific therapeutic needs or recreational desires. It is important to note, however, that the scientific evidence behind the combinations for therapeutic optimization is still primarily theoretical.


Is vaping safer than smoking cigarettes?


Over the past few years, there has been no controlled and randomized study directly comparing the safety of smoking and using electronic cigarettes using a standard causal inference model.


However, the belief that e-cigarettes do not harm the lungs may be a misconception. A study conducted in 2020 among 2,553 young people found that using e-cigarettes for marijuana at any time increased the risk of developing bronchial symptoms, such as shortness of breath. This result persisted even after adjusting for nicotine e-cigarettes and using marijuana or tobacco.


Last month, it was reported that using an electronic cigarette at least three times can double the risk of wheezing. Wheezing occurs when a person's airways become partially obstructed and they make a short whistling or rattling sound while breathing. However, it is important to note that the potential impact of previous exposure to vitamin E on the lungs cannot be ruled out as we approach the era of vitamin E acetate.


Studies on electronic cigarettes clearly indicate that they are associated with adverse effects on the lungs and airways. Even without nicotine, inflammation in the airways may be caused by the vaping liquid itself, suggesting that some of these effects may also extend to the vaporization of cannabinoids.


The anti-inflammatory properties of tetrahydrocannabinol (THC) and cannabidiol (CBD), particularly when used together, may counteract some of the inflammatory effects of cannabis vaporization. However, respiratory irritation is typically reported with cannabis vaporization, indicating that some level of inflammation may still occur.


When consuming unregulated e-cigarette products, there may be additional health issues that arise. While vitamin E acetate has largely disappeared from vape products, heating it can release destructive gases that contributed to the 2019 EVALI epidemic, which can be produced by other compounds found in unregulated delta-8, CBN, and CBG e-cigarette products. It is crucial to understand the contents of one's e-cigarette shopping cart for safe use.


Is there a difference in the effects between vaping and smoking?


The results of studies comparing smoking and vaping cannabis highlight the challenges researchers face when examining these consumption methods. Differences in usage history, frequency, and natural physiological variances can affect the levels of cannabinoids that enter the body and how long they remain.


In a study, when inhalation amounts were strictly controlled, there was no significant difference in the levels of tetrahydrocannabinol or other cannabinoids collected in the blood using these two methods.


However, in a study on infrequent marijuana users (meaning no use in the past 30 days), vaporizing was found to cause an increase in tetrahydrocannabinol (THC) content in the blood compared to smoking, resulting in greater impairment on various cognitive, visual, and subjective measures.


Similarly, another study investigated how smoking and e-cigarette use affect appetite and metabolism-related hormones after consuming a standard breakfast. While both smoking and vaping marijuana lowered insulin levels, smoking marijuana resulted in a greater decrease in insulin levels 15 minutes after use.


The decrease of insulin can partially explain the low incidence of type II diabetes among regular cannabis users, a disease that originates from excessive release of insulin and ultimately leads to insulin resistance.


Which is better? Smoking or vaping?


The EVALI panic of 2019 tarnished the safety reputation of vape devices in the eyes of the public, media, and research community. Reports of harm caused by cannabis vaporization may lead to "white hat bias" - where people unintentionally distort information to fit societal expectations or personal views of the industry.


In this situation, the historical illegality and ingrained societal beliefs about the harmful effects of marijuana may lead to the idea that consuming marijuana, even if no more harmful than smoking tobacco, is equally harmful.


Some individuals may report that although there is a lack of evidence indicating an increase in the harm of electronic cigarettes, their subjective experiences align with these beliefs. However, although most devices no longer contain publicly harmful additives that caused hospitalization and death during the EVALI outbreak, illegal and unapproved devices and e-cigarette liquids continue to circulate.


Studies comparing the long-term safety and health effects of smoking and electronic cigarettes have typically captured the extended usage of these unregulated products, which are more easily accessible. However, it remains difficult to draw conclusions regarding the long-term safety of electronic cigarettes based on existing devices and e-liquids.


There is no significant difference in the impact of acute smoking and e-cigarette use on the concentration of cannabinoids in the body. However, the differences in puff patterns between smoking a bowl and using an e-cigarette may have varying effects on the brain and body. Ultimately, as with most cannabis products, understanding its contents, the reputation of its source, and regulating intake are the key factors for safe and effective use.


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not reflect the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is only for industry communication and research purposes.


Due to limitations in the translation process, the translated article may not fully reflect the original text. Therefore, please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international matters and positions.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean lawmaker Jeong Jin-wook has again called for stronger government action against liquid synthetic nicotine vape manufacturers and sellers, alleging that some businesses may have avoided regulation through product labeling changes and corporate restructuring. According to Newsworks, JNILBO and other Korean reports, Jeong has held his third press conference on the issue, calling for a government-wide investigation. The dispute involves whether synthetic nicotine products should fall under tobacco regulations, tax implications and supply-chain transparency. South Korean government agencies have previously said some estimates of potential tax losses cannot be verified due to limited sales data.
Jul.27
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia will place e-cigarettes and related nicotine products under its “strategic goods” framework from August 20, 2026. According to TVP World’s report published on August 19, the newly listed items include e-cigarettes, electronic smoking devices, vape liquids and nicotine salts. Individuals who illegally move these products across Russia’s customs border or its state border with other Eurasian Economic Union (EAEU) members could face up to five years in prison if shipment values exceed 100,000 rubles (about €1,000), provided all elements of a criminal offence are established.
Aug.20
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01